Merck researchers developed a highly sustainable way to synthesize the macrocyclic peptide drug enlicitide, increasing patient access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results